Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent

San Francisco, CA, Feb. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Oncology Pharma Inc.(OTC: ONPH) is pleased to announce that it has executed a world-wide Licensing Agreement with Sybleu Inc. for itsCancer therapy by intratumoral injection of a chemotherapeutic agent in combination with a bioactive immunostimulatory agent.